Powered by: Motilal Oswal
2026-02-06 03:38:32 pm | Source: Accord Fintech
Godavari Biorefineries trades jubilantly on partnering with Synthomer
Godavari Biorefineries trades jubilantly on partnering with Synthomer

Godavari Biorefineries is currently trading at Rs. 287.70, up by 32.10 points or 12.56% from its previous closing of Rs. 255.60 on the BSE.

The scrip opened at Rs. 254.05 and has touched a high and low of Rs. 295.25 and Rs. 250.30 respectively. So far 164579 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 352.00 on 24-Jul-2025 and a 52 week low of Rs. 145.20 on 28-Mar-2025.

Last one week high and low of the scrip stood at Rs. 295.25 and Rs. 243.70 respectively. The current market cap of the company is Rs. 1466.45 crore.

The promoters holding in the company stood at 63.31%, while Institutions and Non-Institutions held 12.02% and 24.67% respectively.

Godavari Biorefineries has entered into partnership with Synthomer to develop bio based alternatives to existing fossil based monomers. With growing customer demand for more sustainable alternatives, this partnership strengthens the company’s commitment to innovation and reinforces its focus on delivering customer-centric, lower carbon solutions.

Through this partnership, Synthomer is commercialising bio-based butyl acrylate using bio-based butanol produced by the company, helping to accelerate the industry’s transition to more sustainable raw materials.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here